Trial Profile
An prospective, observational study to evaluate safety and efficacy of concurrent administration of influenza vaccine in patients undergoing anti-PD-1 immunotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 12 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology